• Reuters

  • SHARE

Researchers in the United States trying to develop a vaccine against the deadly Middle East respiratory syndrome (MERS) virus say they have had early signs of success in animal experiments.

Using a two-step approach in mice and rhesus macaques, scientists at the vaccine research center of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said they had managed to provoke an immune response in the animals.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)